Getinge Acquires High Purity New England

Getinge Acquires Healthmark Industries Co. Inc.

October 11, 2023

Medical Devices

Getinge (Gothenburg, Sweden) has acquired 100% of Healthmark Industries Co. Inc. (Fraser, Michigan, USA) for approximately USD 320 million, a deal that closed following the HSR waiting period. Healthmark, a maker of instrument-care and infection-control consumables with ~400 employees and expected FY2023 net sales of about USD 126 million, will complement Getinge’s sterile reprocessing equipment, consumables and software and accelerate Healthmark’s international expansion.

Getinge Acquires Paragonix Technologies

August 22, 2024

Medical Devices

Getinge has completed the acquisition of Paragonix Technologies, a U.S. developer of organ preservation devices and transplant logistics services, for an estimated total consideration of USD 477 million (including earn-outs). The deal will make Paragonix a wholly owned subsidiary of Getinge and is intended to expand Getinge's transplant product portfolio and bring Paragonix's technologies to new global markets.

Bionano Genomics Acquires Purigen Biosystems

November 28, 2022

Biotechnology

Bionano Genomics agreed to acquire Purigen Biosystems to integrate Purigen's isotachophoresis (ITP) Ionic Purification System into Bionano's optical genome mapping (OGM) workflow, aiming to simplify ultra-high molecular weight (UHMW) DNA isolation and address difficult sample types. The deal consideration is up to $64 million (including $32 million cash at closing and milestone-contingent payments) and was expected to close by December 8, 2022.

Edgewater Capital Partners Acquires Haematologic Technologies

October 11, 2019

Biotechnology

Edgewater Capital Partners has entered into an agreement to acquire Haematologic Technologies Incorporated, a Vermont-based provider of biologic products, reagents and GMP-compliant assay development and testing services for the biopharmaceutical industry. Edgewater said it will support HTI's next phase of growth and build the company as a premier outsourced services partner for biologics; financial terms were not disclosed.

HGS BioScience Acquires Pharmgrade

January 13, 2026

Agriculture

Paine Schwartz Partners–backed HGS BioScience has acquired Pharmgrade, an Idaho-based developer of microbial consortium products, to strengthen its microbial capabilities and expand its integrated biologicals platform. The deal enhances HGS's R&D, formulation and manufacturing depth and helps scale Pharmgrade’s microbial technologies to retailers and growers across North America.

BioNTech Acquires Neon Therapeutics

January 16, 2020

Biotechnology

BioNTech SE will acquire Neon Therapeutics, Inc. in an all-stock transaction valued at approximately $67.0 million. Neon, a Cambridge-based developer of neoantigen-targeted T cell therapies, will become a wholly owned subsidiary of BioNTech to expand BioNTech’s T cell therapy capabilities and U.S. presence.